Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | BMY | AMGN | GILD | REGN |
| Company | Clovis Oncology Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.7000 | 79.84 | 245.93 | 62.83 | 600.67 |
| High | 1.8500 | 80.40 | 247.58 | 63.49 | 604.33 |
| Low | 1.6200 | 78.49 | 243.39 | 62.13 | 593.63 |
| Last | 1.7100 | 78.70 | 243.51 | 62.21 | 594.42 |
| Change | unch | -1.28 | -1.34 | -0.62 | -7.98 |
| % Change | unch | -1.60% | -0.55% | -0.99% | -1.32% |
| Volume | 7,427,600 | 8,869,900 | 2,430,000 | 6,165,200 | 534,100 |
| 20-Day Average Volume | 18,305,805 | 14,165,765 | 3,862,955 | 8,230,955 | 862,860 |
| Previous Close | 1.7100 | 79.98 | 244.85 | 62.83 | 602.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0464 | 75.70 | 242.74 | 61.49 | 597.53 |
| 20-Day Raw Stochastic | 62.07% | 78.72% | 49.23% | 61.71% | 36.44% |
| 20-Day Relative Strength | 62.97% | 59.58% | 50.84% | 51.72% | 43.71% |
| Weighted Alpha | -77.02 | +24.34 | +2.46 | -10.68 | -3.52 |
| Today's Opinion | 40% Sell | 88% Buy | 56% Buy | 16% Sell | 72% Sell |
| Previous Opinion | 40% Sell | 88% Buy | 72% Buy | 16% Sell | 72% Sell |
| Last Month's Opinion | 100% Sell | 96% Buy | 88% Buy | 24% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.27% since 06/21/22 | +2.92% since 06/21/22 | +2.14% since 06/21/22 | +2.81% since 06/21/22 | +1.15% since 06/21/22 |
| Low | 1.3400 on 06/23/22 | 76.20 on 06/22/22 | 236.90 on 06/22/22 | 60.09 on 06/22/22 | 580.72 on 06/22/22 |
| High | 1.9100 on 06/24/22 | 80.59 on 06/27/22 | 247.58 on 06/28/22 | 63.53 on 06/27/22 | 613.15 on 06/24/22 |
| 1-Month | |||||
| %Chg | +147.83% since 05/27/22 | +3.36% since 05/27/22 | -4.60% since 05/27/22 | -4.00% since 05/27/22 | -14.20% since 05/27/22 |
| Low | 0.5810 on 06/13/22 | 71.71 on 06/16/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 2.4000 on 06/21/22 | 80.59 on 06/27/22 | 257.97 on 06/01/22 | 65.34 on 06/01/22 | 692.80 on 05/31/22 |
| 3-Month | |||||
| %Chg | +11.04% since 03/28/22 | +7.65% since 03/28/22 | +1.26% since 03/28/22 | +5.12% since 03/28/22 | -14.27% since 03/28/22 |
| Low | 0.5810 on 06/13/22 | 71.71 on 06/16/22 | 227.32 on 05/02/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 3.1400 on 04/06/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | -38.27% since 12/28/21 | +26.22% since 12/28/21 | +7.86% since 12/28/21 | -14.75% since 12/28/21 | -6.90% since 12/28/21 |
| Low | 0.5810 on 06/13/22 | 60.86 on 01/06/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 3.1400 on 04/06/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 246,033 | 170,282,544 | 130,798,880 | 78,808,488 | 65,383,896 |
| Shares Outstanding, K | 143,879 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 148,760,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -264,520,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 34,250,000 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -60,170,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | 1.63 | 0.49 | 0.57 | 0.37 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 05/04/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 08/03/22 | 07/27/22 | 08/02/22 | 08/04/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 03/31/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.23 | 13.89 | 8.61 | 7.80 |
